Design and synthesis of dipeptide nitriles as reversible and potent cathepsin S inhibitors

被引:83
作者
Ward, YD [1 ]
Thomson, DS [1 ]
Frye, LL [1 ]
Cywin, CL [1 ]
Morwick, T [1 ]
Emmanuel, MJ [1 ]
Zindell, R [1 ]
McNeil, D [1 ]
Bekkali, Y [1 ]
Giradot, M [1 ]
Hrapchak, M [1 ]
De Turi, M [1 ]
Crane, K [1 ]
White, D [1 ]
Pav, S [1 ]
Wang, Y [1 ]
Hao, MH [1 ]
Grygon, CA [1 ]
Labadia, ME [1 ]
Freeman, DM [1 ]
Davidson, W [1 ]
Hopkins, JL [1 ]
Brown, ML [1 ]
Spero, DM [1 ]
机构
[1] Boehringer Ingelheim Pharmaceut Inc, Dept Med Chem, Ridgefield, CT 06877 USA
关键词
D O I
10.1021/jm020209i
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The specificity of the immune response relies on processing of foreign proteins and presentation of antigenic peptides at the cell surface. Inhibition of antigen presentation, and the subsequent activation of T-cells, should, in theory, modulate the immune response. The cysteine protease Cathepsin S performs a fundamental step in antigen presentation and therefore represents an attractive target for inhibition. Herein, we report a series of potent and reversible Cathepsin S inhibitors based on dipeptide nitriles. These inhibitors show nanomolar inhibition of the target enzyme as well as cellular potency in a human B cell line. The first X-ray crystal structure of a reversible inhibitor cocrystallized with Cathepsin S is also reported.
引用
收藏
页码:5471 / 5482
页数:12
相关论文
共 46 条
[41]   Cathepsin S required for normal MHC class II peptide loading and germinal center development [J].
Shi, GP ;
Villadangos, JA ;
Dranoff, G ;
Small, C ;
Gu, LJ ;
Haley, KJ ;
Riese, R ;
Ploegh, HL ;
Chapman, HA .
IMMUNITY, 1999, 10 (02) :197-206
[42]   Proteolysis in MHC class II antigen presentation: Who's in charge? [J].
Villadangos, JA ;
Ploegh, HL .
IMMUNITY, 2000, 12 (03) :233-239
[43]   Proteases involved in MHC class II antigen presentation [J].
Villadangos, JA ;
Bryant, RAR ;
Deussing, J ;
Driessen, C ;
Lennon-Duménil, AM ;
Riese, RJ ;
Roth, W ;
Saftig, P ;
Shi, GP ;
Chapman, HA ;
Peters, C ;
Ploegh, HL .
IMMUNOLOGICAL REVIEWS, 1999, 172 :109-120
[44]   Structure and design of potent and selective cathepsin K inhibitors [J].
Yamashita, DS ;
Smith, WW ;
Zhao, BG ;
Janson, CA ;
Tomaszek, TA ;
Bossard, MJ ;
Levy, MA ;
Oh, HJ ;
Carr, TJ ;
Thompson, SK ;
Ijames, CF ;
Carr, SA ;
McQueney, M ;
DAlessio, KJ ;
Amegadzie, BY ;
Hanning, CR ;
AbdelMeguid, S ;
DesJarlais, RL ;
Gleason, JG ;
Veber, DF .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1997, 119 (46) :11351-11352
[45]  
1996, BIOCHEM, V35, P16749
[46]  
2000, Patent No. 0048992